Phase 3 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman diagnosed with cervical cancer that has been confirmed by a tissue biopsy and has spread to lymph nodes near the large blood vessel in the abdomen (called para-aortic lymph nodes), confirmed by a special scan or surgical biopsy
- Your cancer is at a stage between IB1 and IVA (meaning it has not spread to distant organs beyond the para-aortic lymph nodes)
- Your cancer is one of these types: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
- You are well enough to carry out light daily activities (your general health is rated as reasonably good by your doctor)
- Your kidneys are working well enough (confirmed by a blood test)
- Your liver is working well enough (confirmed by a blood test)
- Your blood counts (platelets and white blood cells) are at acceptable levels
- You are willing and able to give written consent to take part
Who may not be able to join:
- Your cervical cancer has already spread to distant parts of the body beyond the abdomen (stage IVB)
- Your cervical cancer is a type other than squamous cell, adenocarcinoma, or adenosquamous carcinoma
- You have already received chemotherapy for your cervical cancer
- You are currently pregnant or breastfeeding
- You have had another cancer (other than certain common skin cancers) within the last 5 years
- Your kidneys, liver, or blood counts are not working at the required levels
- You have a significant heart condition affecting your daily activity (confirm with trial site)
- You already have moderate or severe nerve damage causing symptoms such as numbness or tingling in your hands or feet (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stéphanie MOTTON, MD, University Hospital, Toulouse
Phone: +335 61 32 37 08
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.